AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 93 filers reported holding AVROBIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $11,152,000 | -36.3% | 800,000 | -28.9% | 0.22% | -60.4% |
Q1 2020 | $17,503,000 | -25.4% | 1,124,879 | -3.4% | 0.56% | -25.8% |
Q4 2019 | $23,451,000 | +232.2% | 1,164,970 | +133.0% | 0.75% | +159.7% |
Q3 2019 | $7,060,000 | +23.6% | 500,000 | +150.0% | 0.29% | +43.3% |
Q2 2018 | $5,712,000 | – | 200,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |